Learn More
Description
Reacts with TWEAK, or TNF-like weak inducer of apoptosis, a type II transmembrane protein of approximately 1.4 kDa. It is present as a cell surface bound or a secreted form, expressed on most tissues and non-lymphoid tumor cell lines, but weak or no expression on hematopoietic lineage lines. TWEAK is not detectable on resting PBMC, but its expression on peripheral blood monocytes is upregulated upon IFN-g stimulation. Reports indicate that TWEAK interacts with its receptor APO-3 and this interaction can lead to apoptosis, IL-8 secretion, NF-kB activation and endothelial cell proliferation. Clone CARL-2, a different monoclonal antibody, also reacts with TWEAK but to a different epitope.
Host Species: Mouse
Clone: CARL-1
Isotype: IgG3 κ
Species Reactivity: Human
Flow Cytometry
Specifications
Specifications
| Antigen | TWEAK |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | CARL-1 |
| Conjugate | PE |
| Description | CD255; TWEAK; TNFSF12; APO3 ligand; APO3L; DR3LG |
| Formulation | Aqueous buffered solution containing BSA, protein stabilizer, and ≤0.09% sodium azide. |
| Host Species | Mouse |
| Immunogen | Human Tweak Transfected Cell Line |
| Purification Method | Affinity Purified |
| Show More |
For Research Use Only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.